← back to search

Jin Ma

Guangzhou University of Chinese Medicine · CN
🔎 Find collaborators in Cardiology and Cardiovascular Medicine · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cardiology and Cardiovascular Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Internal medicine, Fibrosis, Atrial fibrillation, Cardiology, and Myofibroblast.
h-index
citations
387
works
18
NIH funding
primary concept
email

Recent publications

The Role of Infarct Border Zone Remodelling in Ventricular Arrhythmias: Bridging Basic Research and Clinical Applications
Journal of Cellular and Molecular Medicine 2025cited by 3position: firstdoi
[Current status of diagnosis and treatment of chronic lymphocytic leukemia in China: A national multicenter survey research].
PubMed 2023cited by 0position: middledoi
Danqi soft caspule prevents atrial fibrillation by ameliorating left atrial remodeling through inhibiting cardiac fibroblasts differentiation and function
Phytomedicine 2022cited by 10position: firstdoi
[Retracted] Identifying the Effect of Nuanxin Capsules on Myocardial Injury Induced by Chronic Hypoxia via Network Pharmacology Analysis and Experimental Validation
BioMed Research International 2022cited by 1position: middledoi
Left atrial fibrosis in atrial fibrillation: Mechanisms, clinical evaluation and management
Journal of Cellular and Molecular Medicine 2021cited by 113position: firstdoi
Nuanxin capsule enhances cardiac function by inhibiting oxidative stress-induced mitochondrial dependent apoptosis through AMPK/JNK signaling pathway
Biomedicine & Pharmacotherapy 2021cited by 19position: middledoi
Deciphering mechanism of the herbal formula WuShen in the treatment of postinfarction heart failure
Phytomedicine 2021cited by 6position: middledoi
[Relationship between programmed cell death and myocardial ischemia-reperfusion injury and new perspectives of traditional Chinese medicine intervention].
PubMed 2021cited by 5position: middledoi
Isoproterenol Increases Left Atrial Fibrosis and Susceptibility to Atrial Fibrillation by Inducing Atrial Ischemic Infarction in Rats
Frontiers in Pharmacology 2020cited by 23position: middledoi
Danqi soft capsule prevents infarct border zone remodelling and reduces susceptibility to ventricular arrhythmias in post‐myocardial infarction rats
Journal of Cellular and Molecular Medicine 2019cited by 38position: middledoi
Tongguan capsule derived-herb ameliorates remodeling at infarcted border zone and reduces ventricular arrhythmias in rats after myocardial infarction
Biomedicine & Pharmacotherapy 2019cited by 18position: middledoi
Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure
Drug Design Development and Therapy 2018cited by 28position: firstdoi
Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties
Journal of Cardiovascular Electrophysiology 2018cited by 27position: firstdoi
DL-3-n-butylphthalide improves ventricular function, and prevents ventricular remodeling and arrhythmias in post-MI rats
Naunyn-Schmiedeberg s Archives of Pharmacology 2018cited by 17position: middledoi
Tongguan capsule‐derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts
Journal of Cellular and Molecular Medicine 2018cited by 8position: middledoi
DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure
Naunyn-Schmiedeberg s Archives of Pharmacology 2017cited by 27position: middledoi
Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1
Chinese Journal of Integrative Medicine 2016cited by 44position: firstdoi
GW25-e4167 QiShen YiQi Pills ameliorates ventricular fibrosis and dysfunction via regulation the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the isoproterenol-induced myocardial fibrosis rats
Journal of the American College of Cardiology 2014cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shiyu Ma · Fudan University12 papers (2016–2025)Chunhua Ding · Guangzhou University of Chinese Medicine5 papers (2014–2021)Qiuxiong Chen · Guangzhou University of Chinese Medicine5 papers (2018–2025)Huiliang Qiu · Mayo Clinic in Arizona4 papers (2017–2021)Minzhou Zhang · Guangzhou University of Chinese Medicine3 papers (2018–2019)Huanlin Wu · Guangzhou University of Chinese Medicine3 papers (2017–2021)Liheng Guo · Guangzhou University of Chinese Medicine3 papers (2018–2019)Chaoyang Zheng · Guangzhou University of Chinese Medicine3 papers (2018–2022)Wencong Qiu · Guangzhou University of Chinese Medicine2 papers (2017–2021)Ye Fan · Guangzhou University of Chinese Medicine2 papers (2021–2022)Haiming Cao · Guangzhou University of Chinese Medicine2 papers (2017–2021)Weihui Lv · Guangzhou University of Chinese Medicine2 papers (2018–2020)Chunxia Yin · Guangzhou University of Chinese Medicine2 papers (2018–2018)Yanzheng Xie · Guangzhou University of Chinese Medicine2 papers (2021–2021)Junqi Bai · Guangzhou University of Chinese Medicine2 papers (2018–2019)Gengzhen Yao · Guangzhou University of Chinese Medicine2 papers (2021–2021)Tiantian Lou · Guangzhou University of Chinese Medicine2 papers (2021–2022)Minzhou Zhang · Guangzhou University of Chinese Medicine1 papers (2014–2014)Weihui Lu · Guangzhou University of Chinese Medicine1 papers (2021–2021)Xiaoqing Li · Guangzhou University of Chinese Medicine1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cardiology and Cardiovascular Medicine · Pulmonary and Respiratory Medicine →